Login
Résultat de la recherche (1-20 par 85)Download
|
Symbol
|
RMA0EV | RMA72V | RMASDV | ABWQSQ | CHLBKB | ABITTQ | RMBQ3V | RMBQ5V | PEYRCH | CGJBKB | PGJRCH | RMBHUV | ABJTTQ | ABNSTQ | RMBRSV | RMA7JV | ABOMTQ | RMBAIV | PKRRCH | ABUBTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | Roche PS / Sonova Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Helvetia Baloise Holding AG / Ypsomed Hldg. AG / Sandoz Group AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Bachem Hldg. AG / Sandoz Group AG / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Alcon / Roche PS / Siegfried Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | DOCMORRIS AG / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Alcon / Lonza Group N / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Ypsomed Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
15.06.2026 | 31.08.2026 | 11.05.2026 | 08.05.2026 | 11.05.2026 | 06.05.2026 | 18.05.2026 | 17.11.2026 | 18.05.2026 | 05.05.2026 | 22.05.2026 | 01.06.2026 | 12.05.2026 | 26.05.2026 | 22.05.2026 | 21.12.2026 | 03.06.2026 | 30.12.2026 | 30.06.2026 | 30.12.2026 |
| Demande | 25,800 | 69,10 | 67,50 | 55,07 | 102,04 | 73,32 | 98,80 | 39,500 | 68,64 | - | 55,75 | - | 69,29 | 79,34 | - | 90,30 | 58,74 | 46,900 | 97,02 | 93,52 |
| Offre | - | - | - | - | 102,86 | - | 100,40 | - | - | - | - | - | - | - | - | - | - | - | - | 94,32 |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)